Revisiting the compound muscle action potential (CMAP).
Waveform changes of compound muscle action potential (CMAP) with muscle length.
Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
Nerve conduction studies: Basic concepts.
Tavee J.
Handb Clin Neurol. 2019;160:217-224. doi: 10.1016/B978-0-444-64032-1.00014-X.
Compound muscle action potential (CMAP) scan examination of paretic and contralateral muscles reveals motor unit alterations after stroke.
Chen M, Lu Z, Li X, Zong Y, Xie Q, Li S, Zhou P.
Sci China Life Sci. 2023 Nov;66(11):2604-2613. doi: 10.1007/s11427-022-2308-8. Epub 2023 May 29.
Far-field potentials in the compound muscle action potential.
Sonoo M.
Muscle Nerve. 2020 Mar;61(3):271-279. doi: 10.1002/mus.26743. Epub 2019 Nov 20.
A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy.
Barrois R, Barnerias C, Deladrière E, Leloup-Germa V, Tervil B, Audic F, Boulay C, Cances C, Cintas P, Davion JB, Espil-Taris C, Manel V, Pereon Y, Piarroux J, Quijano Roy S, Vuillerot C, Walther-Louvier U, Desguerre I, Gitiaux C.
Neuromuscul Disord. 2023 Apr;33(4):309-314. doi: 10.1016/j.nmd.2023.02.004. Epub 2023 Feb 11.
Peripheral Nerve Injuries: Electrophysiology for the Neurosurgeon.
Kamble N, Shukla D, Bhat D.
Neurol India. 2019 Nov-Dec;67(6):1419-1422. doi: 10.4103/0028-3886.273626.
Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and Prognostication.
Shelly S, Soontrapa P, Madigan NN, Polzin MJ, Singh TD, Sista SRS, Paul P, Braksick SA, Liao B, Windebank AJ, Boon AJ, Litchy WJ, Milone M, Liewluck T.
Neurology. 2024 Jul 9;103(1):e209496. doi: 10.1212/WNL.0000000000209496. Epub 2024 Jun 13.
Analysis of the compound muscle action potential scan: Step index (STEPIX) and amplitude index (AMPIX).
Nandedkar SD, Barkhaus PE, Stålberg EV.
Clin Neurophysiol. 2022 Jul;139:119-127. doi: 10.1016/j.clinph.2022.04.011. Epub 2022 Apr 26.
Prior muscle activation affects the compound muscle action potential.
Peterson GW, Tsao BE, Nist LD, Estevez D, Brandstater ME.
Muscle Nerve. 2019 Jul;60(1):25-31. doi: 10.1002/mus.26463. Epub 2019 Mar 25.
Far-field potential of the compound muscle action potential as a reliable marker in amyotrophic lateral sclerosis.
Higashihara M, Yamazaki H, Izumi Y, Kobayashi M, Nodera H, Oishi C, Iwata A, Murayama S, Kaji R, Sonoo M.
Muscle Nerve. 2023 Sep;68(3):257-263. doi: 10.1002/mus.27829. Epub 2023 Apr 22.
Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP.
Kitaoji T, Noto YI, Kojima Y, Tsuji Y, Kitani-Morii F, Mizuno T, Nakagawa M.
Clin Neurophysiol. 2023 Feb;146:124-130. doi: 10.1016/j.clinph.2022.12.004. Epub 2022 Dec 22.
